000 | 01760 a2200541 4500 | ||
---|---|---|---|
005 | 20250515064358.0 | ||
264 | 0 | _c20070830 | |
008 | 200708s 0 0 fre d | ||
022 | _a0755-4982 | ||
024 | 7 |
_a10.1016/j.lpm.2007.03.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDenjoy, Isabelle | |
245 | 0 | 0 |
_a[Brugada syndrome]. _h[electronic resource] |
260 |
_bPresse medicale (Paris, France : 1983) _c |
||
300 |
_a1109-16 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 | _aAnti-Arrhythmia Agents |
650 | 0 | 4 |
_aAsia _xepidemiology |
650 | 0 | 4 |
_aBrugada Syndrome _xdiagnosis |
650 | 0 | 4 |
_aBundle-Branch Block _xetiology |
650 | 0 | 4 | _aContraindications |
650 | 0 | 4 |
_aDeath, Sudden, Cardiac _xetiology |
650 | 0 | 4 | _aDecision Trees |
650 | 0 | 4 | _aDefibrillators, Implantable |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 |
_aFrance _xepidemiology |
650 | 0 | 4 |
_aGenes, Dominant _xgenetics |
650 | 0 | 4 | _aGenetic Counseling |
650 | 0 | 4 | _aGenetic Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMuscle Proteins _xgenetics |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 | _aNAV1.5 Voltage-Gated Sodium Channel |
650 | 0 | 4 | _aPenetrance |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aPsychotropic Drugs |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aSodium Channels _xgenetics |
650 | 0 | 4 |
_aSyncope _xetiology |
650 | 0 | 4 |
_aTachycardia, Ventricular _xetiology |
700 | 1 | _aExtramiana, Fabrice | |
700 | 1 | _aLupoglazoff, Jean-Marc | |
700 | 1 | _aLeenhardt, Antoine | |
773 | 0 |
_tPresse medicale (Paris, France : 1983) _gvol. 36 _gno. 7-8 _gp. 1109-16 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lpm.2007.03.019 _zAvailable from publisher's website |
999 |
_c16995909 _d16995909 |